Search
for
Sort by
Research 601–630 of 1000+
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
- Androgens and ovarian function: translation from basic discovery research to clinical impact
- Management of Hirsutism
- Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
- Treatment of hirsutism and acne in hyperandrogenism
- EFFECTS OF A LOW‐DOSE DESOGESTREL‐ETHINYLESTRADIOL COMBINATION ON HIRSUTISM, ANDROGENS AND SEX HORMONE BINDING GLOBULIN IN WOMEN WITH A POLYCYSTIC OVARY SYNDROME
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran
- Suppression of uterine and placental ferroptosis by N-acetylcysteine in a rat model of polycystic ovary syndrome
- Endocrine and metabolic characteristics in polycystic ovary syndrome.
- Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome
- Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women
- Clinician vs Self-ratings of Hirsutism in Patients With Polycystic Ovarian Syndrome
- Androgen Profiling by Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS) in Healthy Normal-Weight Ovulatory and Anovulatory Late Adolescent and Young Women
- Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome
- Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
- ANTIANDROGEN TREATMENT OF POLYCYSTIC OVARY SYNDROME
- The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study
- Elevated Ghrelin Plasma Levels in Patients with Polycystic Ovary Syndrome
- Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome
- MicroRNA Species in Follicular Fluid Associating With Polycystic Ovary Syndrome and Related Intermediary Phenotypes
- Clinical biochemistry of dihydrotestosterone
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- Health-related quality of life and psychological distress in polycystic ovary syndrome: a hidden facet in South Asian women
- Polycystic Ovary Syndrome: Early Detection in the Adolescent
- Finasteride in the treatment of hirsutism: new therapeutic perspectives
- Polycystic Ovary Syndrome: An Updated Overview Foregrounding Impacts of Ethnicities and Geographic Variations
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: a review
- Differential Suppression of Testosterone and Estradiol in Hirsute Women With the Superactive Gonadotropin-Releasing Hormone Agonist Leuprolide*